Gainers on news: NPS Pharmaceuticals (NPSP +4.37%) Mentioned positively by Jim Cramer Cleveland BioLabs (CBLI +4.14%) Announced that the Department of Defense Chemical Biological and Medical Systems continued funding under development contract for Entolimod (CBLB502) Dynavax (DVAX +4.11%) Hearing positive commentary about potential approval for co's drug Heplisav vaccineDecliners on news: AthenaHealth (ATHN -2.02%) Seeing selling pressure following McKesson (MCK) acquisition of PSS World Med (PSSI)
Upgrades/Downgrades: Galena Biopharma (GALE +6.41%) Initiated with a Buy at MLV & Co Vermillion (VRML +4.8%) Upgraded to Neutral at Ladenburg Thalmann Regeneron Pharmaceuticals (REGN -1.33%) Hearing estimates raised at Goldman; positively mentioned at Lazard Cubist Pharmaceuticals (CBST -2.12%) Initiated with a Sell at Cantor Fitzgerald, target $37 Greenway Medical (GWAY -7.66%) Downgraded to Market Perform at Raymond James.






